Baxter (BAX) rated Hold with a $25 target and 2.6% upside. BAX trades at a discount to the sector. See here for a detailed ...
Baxter International is gearing up to report its third-quarter results later this month, and analysts anticipate a sharp ...
Fintel reports that on 7 October 2026, Barclays initiated coverage of Baxter International (LSE:0QK8) with a Underweight recommendation. This initiation follows a prior action on 4 May 2026, when ...
Fintel on MSN
Barclays initiates coverage of Baxter International Inc. - depositary receipt at underweight
Fintel reports that on October 7, 2026, Barclays initiated coverage of Baxter International Inc. - Depositary Receipt (BOVESPA:B1AX34) with a Underweight recommendation. This action on October 7, 2026 ...
Baxter International stock costs EUR 21.27 on October 8, 2026 after EUR 21.57. Becton Dickinson NYSE Börsenparkett mit ...
Most healthcare organizations have AI governance policies, but 91% can't verify all AI tools in use, a new study finds. As ...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time.
Baxter International has an average rating of hold and mean price target of $26.82, according to analysts polled by FactSet. Price: 24.17, Change: -0.20, Percent Change: -0.80 ...
Baxter International has an average rating of hold and mean price target of $27.60, according to analysts polled by FactSet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results